Thus, from this perspective, abnormally low ATG7 expression in the stromal fibroblasts of breast cancer tissue should disturb the autophagy balance of tumor tissue, which would also facilitate tumor progression and challenge cancer treatment by remodeling the TME. This evidence concerns the gene ATG7 and breast cancer.